In a similar manner, Siderowf et al. evaluated α-syn SAA positivity in the CSF of individuals with iRBD, hyposmia, and carriers of GBA1 or leucine-rich repeat kinase 2 (LRRK2) gene mutations (with or without PD), alongside healthy controls [28]. This evidence concerns the gene LRRK2 and Parkinson disease.